ReviewJournal of oncology2022

A Network Meta-Analysis of the Differences in Effectiveness and Safety between Nivolumab and Targeted Drug Therapy in Metastatic Renal Cell Carcinoma.

Hongchen Qu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.